McGuire Investment Group’s Pacific Biosciences PACB Stock Holding History

McGuire Investment Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,484	Closed	-$348K	–	119
2023 Q4	$348K	Buy	35,484 +8,664	+32%	+$70.9K	0.06%	92
2023 Q3	$224K	Hold	26,820	–	–	0.04%	105
2023 Q2	$357K	Buy	26,820 +6,669	+33%	+$81K	0.07%	88
2023 Q1	$233K	Buy	20,151 +2,000	+11%	+$19.9K	0.05%	100
2022 Q4	$148K	Sell	18,151 -2,000	-10%	-$17.2K	0.03%	109
2022 Q3	$117K	Buy	20,151 +2,000	+11%	+$11.5K	0.03%	109
2022 Q2	$80K	Hold	18,151	–	–	0.02%	116
2022 Q1	$165K	Buy	+18,151	New	+$209K	0.03%	122

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

McGuire Investment Group's PACB Position: Q1 2024 in Review

McGuire Investment Group sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 35,484 shares — an estimated $348K sold.

McGuire Investment Group first reported a position in PACB in Q1 2022 and held it in 8 quarters. The position peaked at $357K in Q2 2023. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

McGuire Investment Group reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
McGuire Investment Group sold 35,484 Pacific Biosciences shares in Q1 2024, an estimated $348K.
McGuire Investment Group first reported a position in Pacific Biosciences in Q1 2022 and held it in 8 quarters.
McGuire Investment Group's Pacific Biosciences position peaked at $357K in Q2 2023.
268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on McGuire Investment Group's 13F filing for Q1 2024, filed 26 Apr 2024.